Literature DB >> 1069268

Synthesis and activities of neurotensin, and its acid and amide analogs: possible natural occurrence of [Gln4]-neurotensin.

K Folkers, D Chang, J Humphries, R Carraway, S E Leeman, C Y Bowers.   

Abstract

It was considered, a priori, that the isolation of the tridecapeptide, neurotensin, might have inadvertently sllowed the hydrolysis of either the [Gln4]- or the [Leu13-NH2]-moieties. Neurotensin and its three acid and amide analogs, i.e., [Gln4]-neurotensin, neurotensin-NH2, and [Gln4]-neurotensin-NH2 were synthesized. Neurotensin and [Gln4]-neurotensin were indistinguishable by the hypotensive assay, hyperglycemic assay, contraction of the ileum, and radioimmunoassay. Neurotensin-NH2 and [Gln4]-neurotensin-NH2 showed less than 1% of these neurotensin activities. Present information does not elucidate whether the glutamic acid residue in position 4 of neurotensin in situ is present as Glu4 or as Gln4. At high levels, neurotensin released the luteinizing hormone, follicle stimulating hormone, and thyrotropin; [Gln4]-neurotensin-NH2 released thyrotropin, and [Gln4]-neurotensin released luteinizing hormone and follicle stimulating hormone, but these activities do not appear biologically significant.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1069268      PMCID: PMC431229          DOI: 10.1073/pnas.73.11.3833

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  11 in total

1.  Factor C-LHIH which inhibits the luteinizing hormone from basal release and from synthetic LHRH and studies on purification of FSHRH.

Authors:  K N Johansson; T Greibrokk; B L Currie; J Hansen; K Folkers
Journal:  Biochem Biophys Res Commun       Date:  1975-03-03       Impact factor: 3.575

2.  The amino acid sequence of a hypothalamic peptide, neurotensin.

Authors:  R Carraway; S E Leeman
Journal:  J Biol Chem       Date:  1975-03-10       Impact factor: 5.157

3.  The synthesis of neurotensin.

Authors:  R Carraway; S E Leeman
Journal:  J Biol Chem       Date:  1975-03-10       Impact factor: 5.157

4.  Identification and purification of factor A-GHRH from hypothalami which releases growth hormone.

Authors:  B L Currie; K N Johansson; T Greibrokk; K Folkers; C Y Bowers
Journal:  Biochem Biophys Res Commun       Date:  1974-09-23       Impact factor: 3.575

5.  Identification and purification of factor B-GHRH from hypothalami which releases growth hormone.

Authors:  K N Johansson; B L Currie; K Folkers; C Y Bowers
Journal:  Biochem Biophys Res Commun       Date:  1974-09-23       Impact factor: 3.575

6.  Purification of a prolactin inhibiting hormone and the revealing of hormone D-GHIH which inhibits the release of growth hormone.

Authors:  T Greibrokk; B L Currie; N K Johansson; J J Hansen; K Folkers
Journal:  Biochem Biophys Res Commun       Date:  1974-07-24       Impact factor: 3.575

7.  On the chemical existence and partial purification of the hypothalamic follicle stimulating hormone releasing hormone.

Authors:  B L Currie; N G Johansson; K Folkers
Journal:  Biochem Biophys Res Commun       Date:  1973-01-04       Impact factor: 3.575

8.  The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami.

Authors:  R Carraway; S E Leeman
Journal:  J Biol Chem       Date:  1973-10-10       Impact factor: 5.157

9.  Deamidation of asparaginyl residues as a hazard in experimental protein and peptide procedures.

Authors:  J H McKerrow; A B Robinson
Journal:  Anal Biochem       Date:  1971-08       Impact factor: 3.365

10.  An improved proceure for blood glucose determination with o-toluidine.

Authors:  G Ceriotti; A De Nadai Frank
Journal:  Clin Chim Acta       Date:  1969-05       Impact factor: 3.786

View more
  6 in total

Review 1.  Glucose transporters in the small intestine in health and disease.

Authors:  Hermann Koepsell
Journal:  Pflugers Arch       Date:  2020-08-23       Impact factor: 3.657

2.  Structure-antinociceptive activity studies with neurotensin.

Authors:  S Furuta; K Kisara; S Sakurada; T Sakurada; Y Sasaki; K Suzuki
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

3.  Identification of N-{[6-chloro-4-(2,6-dimethoxyphenyl)quinazolin-2-yl]carbonyl}-l-leucine (NTRC-808), a novel nonpeptide chemotype selective for the neurotensin receptor type 2.

Authors:  James B Thomas; Angela M Giddings; Srinivas Olepu; Robert W Wiethe; Danni L Harris; Sanju Narayanan; Keith R Warner; Philippe Sarret; Jean-Michel Longpre; Scott P Runyon; Brian P Gilmour
Journal:  Bioorg Med Chem Lett       Date:  2014-11-24       Impact factor: 2.823

4.  Neurotensin and its amide analogue [Gln4]-neurotensin: effects on brain monoamine turnover.

Authors:  J A García-Sevilla; T Magnusson; A Carlsson; J Leban; K Folkers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-12       Impact factor: 3.000

5.  Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels.

Authors:  R Carraway; D E Cochrane; J B Lansman; S E Leeman; B M Paterson; H J Welch
Journal:  J Physiol       Date:  1982-02       Impact factor: 5.182

6.  A multihormonal tumor of the pancreas producing neurotensin.

Authors:  G E Feurle; V Helmstaedter; K Tischbirek; R Carraway; W G Forssmann; D Grube; H D Röher
Journal:  Dig Dis Sci       Date:  1981-12       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.